The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful
Year: 2010
Type: article
Study design: Observational Study
Source: Gut
Institutions: Tel Aviv University, Sheba Medical Center
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2134803931
